Contibution of cardiomyocyte apoptosis to development of congestive heart failure
心肌细胞凋亡对充血性心力衰竭发生的影响
基本信息
- 批准号:12670645
- 负责人:
- 金额:$ 2.43万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Apoptosis plays a pivotal role in loss of cells not only during physiological phenomena, such as normal turnover of tissues, but also in many pathophysiological phenomena. Evidence is accumulating that the apoptotic mechanism is involved in various heart disorders. The Fas/FasL system has been reported to be activated in human heart failure. We observed that cardiomyocyte was generally resistant to Fas-mediated apoptosis in vitro; however, after treatment of sublethal dose of doxorubicin, cardiomyocyte apoptosis was dramatically facilitated by recombinant FasL. This finding is intriguing, because the doxorubicin-induced sensitivity to Fas in cardiomyocyte can be induced by a molecule which may be a target for treating doxorubicin-associated cardiomyopathy. Recently, FLICE-inhibitory protein (FLIP), a molecule with sequence homology to caspase-8 (FLICE), was identified as an anti-apoptotic protein. FLIP is capable of binding FADD, yet is unable to be cleaved to an active caspase-8, thus shutting off the initiation of the death pathway. We observed whether FLIP levels are related to the doxorubicin-induced sensitivity to Fas in cultured neonatal rat cardiomyocyte. Moreover, the expression of FLIP was down-regulated by oxidative stress. FLIP may be a therapeutic target for Dox-induced cardiomyopathy.
细胞凋亡不仅在组织的正常周转等生理现象中,而且在许多病理生理现象中都起着至关重要的作用。越来越多的证据表明,细胞凋亡机制与多种心脏疾病有关。据报道,Fas/FasL系统在人类心力衰竭中被激活。我们观察到,心肌细胞对fas介导的体外凋亡普遍具有抗性;然而,在亚致死剂量的阿霉素处理后,重组FasL显著促进心肌细胞凋亡。这一发现很有趣,因为阿霉素诱导的心肌细胞对Fas的敏感性可以由一种分子诱导,这种分子可能是治疗阿霉素相关心肌病的靶点。近年来,与caspase-8 (FLICE)序列同源的FLICE-inhibitory protein (FLIP)被发现是一种抗凋亡蛋白。FLIP能够结合FADD,但不能与活性caspase-8结合,从而关闭死亡途径的启动。我们观察了FLIP水平是否与阿霉素诱导的新生大鼠心肌细胞对Fas的敏感性有关。此外,氧化应激可下调FLIP的表达。FLIP可能是dox诱导的心肌病的治疗靶点。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Okuyama M, Yamaguchi S, Yamaoka M, Nitobe J, Fujii S, Yoshimura T, Tomoike H: "Nitric oxide enhances expression and shedding of tumor necrosis factor receptor I (p55) in endothelial cells"Arterioscler Thromb Vasc Biol. 20(6). 1506-1511 (2000)
Okuyama M、Yamaguchi S、Yamaoka M、Nitobe J、Fujii S、Yoshimura T、Tomoike H:“一氧化氮增强内皮细胞中肿瘤坏死因子受体 I (p55) 的表达和脱落”Arterioscler Thromb Vasc Biol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Okuyama M. et al: "Nitric oxide enhances expression and shedding of tumor neurosis factor receptor I (p55) in endothelial cells."Arterioscler Thromb Vasc Biol. 20. 1506-1511 (2000)
Okuyama M. 等人:“一氧化氮增强内皮细胞中肿瘤神经症因子受体 I (p55) 的表达和脱落。”Arterioscler Thromb Vasc Biol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yamaoka M, Yamaguchi S, Suzuki T, Okuyama M, Nitobe J, Nakamura N, Mitsui- Y, Tomoike H: "Apoptosis in rat cardiac myocytes induced by Fas ligand: priming for Fas-mediated apoptosis with doxorubicin"J Mol Cell Cardiol. 32(6). 881-889 (2000)
Yamaoka M、Yamaguchi S、Suzuki T、Okuyama M、Nitobe J、Nakamura N、Mitsui-Y、Tomoike H:“Fas 配体诱导的大鼠心肌细胞凋亡:用阿霉素引发 Fas 介导的细胞凋亡”J Mol Cell Cardiol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shirakabe M, et al.: "Impaired distensibility of the left ventricle after stiffening of the right ventricle"J Appl Physiol. 91. 435-440 (2001)
Shirakabe M 等人:“右心室硬化后左心室扩张性受损”J Appl Physiol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Fujiwara S, Takeishi Y, Hirono O, Fukui A, Okuyama, Yamaguchi S, Ito M, Kaneko K, Shishido T, Miyamoto , Yuki K, Miyashita T, Takahashi K, Minamihaba O, Tomo H: "Reverse Redistribution of Technetium-99m-Sestam after Direct PTCA in Acute Myocardial Infarct
Fujiwara S、Takeishi Y、Hirono O、Fukui A、Okuyama、Yamaguchi S、Ito M、Kaneko K、Shishido T、Miyamoto、Yuki K、Miyashita T、Takahashi K、Minamihaba O、Tomo H:“Technetium-99m 的反向再分配
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YAMAGUCHI Seiji其他文献
YAMAGUCHI Seiji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YAMAGUCHI Seiji', 18)}}的其他基金
Development of evaluation method of drug safety for children using cultured cells and tandem mass spectrometry
培养细胞串联质谱法评价儿童用药安全性方法的建立
- 批准号:
22659195 - 财政年份:2010
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Study on relation between acute encephalopathy in childhood and causative disorders of organic and fatty acid metabolism
儿童急性脑病与有机脂肪酸代谢紊乱相关性的研究
- 批准号:
22390208 - 财政年份:2010
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study of metabolic screening, diagnosis, evaluation of treatment, and molecular analysis for organic and fatty acid disorders
有机和脂肪酸疾病的代谢筛查、诊断、治疗评估和分子分析研究
- 批准号:
17390302 - 财政年份:2005
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Clinical and molecular study on Japanese patients with mitochondrial β-oxidation disorders
日本线粒体β-氧化障碍患者的临床和分子研究
- 批准号:
13470165 - 财政年份:2001
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A SYNTHETIC STUDY FOR OPTICALLY ACTIVE 2H-CHROMENE TRIMERS
光学活性2H-铬三聚体的合成研究
- 批准号:
11640529 - 财政年份:1999
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Preliminary studies on neonatal mass screening for organic acidemias using GC/MS
GC/MS 新生儿有机酸血症筛查的初步研究
- 批准号:
10557077 - 财政年份:1998
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Study on biochemical and molecular evoluation for mitochondrial β-oxidation defects
线粒体β-氧化缺陷的生化和分子进化研究
- 批准号:
10470178 - 财政年份:1998
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Development of a system for early diagnosis and molecular analysis of mitochondrial and peroxisomal fatty acid beta-oxidation defects in Japan.
在日本开发了线粒体和过氧化物酶体脂肪酸β-氧化缺陷的早期诊断和分子分析系统。
- 批准号:
08307008 - 财政年份:1996
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
A ROLE OF CYTOKINE IN PROGRESSION OF HEART FAILRE
细胞因子在心力衰竭进展中的作用
- 批准号:
07670750 - 财政年份:1995
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of automated GC/MS data profiling and disease-detection sytems for organic acidemia screening.
开发用于有机酸血症筛查的自动化 GC/MS 数据分析和疾病检测系统。
- 批准号:
07557062 - 财政年份:1995
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
Fas 配体裂解调节眼稳态和青光眼
- 批准号:
10374484 - 财政年份:2022
- 资助金额:
$ 2.43万 - 项目类别:
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
Fas 配体裂解调节眼稳态和青光眼
- 批准号:
10867990 - 财政年份:2022
- 资助金额:
$ 2.43万 - 项目类别:
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
Fas 配体裂解调节眼稳态和青光眼
- 批准号:
10550147 - 财政年份:2022
- 资助金额:
$ 2.43万 - 项目类别:
Mechanisms of Fas Ligand Control of Insulitis in Autoimmune Diabetes
Fas配体控制自身免疫性糖尿病胰岛素炎的机制
- 批准号:
8811093 - 财政年份:2013
- 资助金额:
$ 2.43万 - 项目类别:
Mechanisms of Fas Ligand Control of Insulitis in Autoimmune Diabetes
Fas配体控制自身免疫性糖尿病胰岛素炎的机制
- 批准号:
8627108 - 财政年份:2013
- 资助金额:
$ 2.43万 - 项目类别:
Mechanisms of Fas Ligand Control of Insulitis in Autoimmune Diabetes
Fas配体控制自身免疫性糖尿病胰岛素炎的机制
- 批准号:
8504356 - 财政年份:2013
- 资助金额:
$ 2.43万 - 项目类别:
Mechanisms of Fas Ligand Control of Insulitis Initiation in Autoimmune Diabetes
Fas 配体控制自身免疫性糖尿病胰岛素炎发生的机制
- 批准号:
8440387 - 财政年份:2012
- 资助金额:
$ 2.43万 - 项目类别:
Provoking anti-tumor immune responses with Fas ligand
通过 Fas 配体激发抗肿瘤免疫反应
- 批准号:
7291653 - 财政年份:2006
- 资助金额:
$ 2.43万 - 项目类别:
Soluble Fas Ligand and Ocular Immune Privilege
可溶性 Fas 配体与眼部免疫特权
- 批准号:
7534765 - 财政年份:2004
- 资助金额:
$ 2.43万 - 项目类别:
Soluble Fas Ligand and Ocular Immune Privilege
可溶性 Fas 配体与眼部免疫特权
- 批准号:
7342074 - 财政年份:2004
- 资助金额:
$ 2.43万 - 项目类别:














{{item.name}}会员




